Prevalence and Incidence of Neuroacanthocytosis
Neuroacanthocytosis: Rare Disease
Neuroacanthocytosis is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Neuroacanthocytosis, or a subtype of Neuroacanthocytosis,
affects less than 200,000 people in the US population.
Ophanet, who are a consortium of European partners,
currently defines a condition rare when if affects 1 person per 2,000.
They list Neuroacanthocytosis as a "rare disease".
More information about Neuroacanthocytosis is available from Orphanet
About prevalence and incidence statistics:
The term 'prevalence' of Neuroacanthocytosis usually refers to the estimated population
of people who are managing Neuroacanthocytosis at any given time.
The term 'incidence' of Neuroacanthocytosis refers to the annual diagnosis rate,
or the number of new cases of Neuroacanthocytosis diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.